Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse with links to cc.nih.gov and opm.gov. Updated page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page gains a glossary toggle and updated metadata, including 'Last Update Submitted that Met QC Criteria' and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 as the page revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now presents a single 'Locations' section listing Ohio and Pennsylvania, replacing the separate 'Ohio Locations' and 'Pennsylvania Locations' entries. The 'HHS Vulnerability Disclosure' footer link was removed and the page revision updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision history updated: added v3.3.2 and removed v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.